Novartis announces plan to initiate clinical trial of canakinumab for patients with COVID-19 pneumonia Read more
Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19 Read more
Novartis Kymriah receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma Read more
Gilead, Kite and oNKo-innate Announce Research Collaboration to Discover Cancer Immunotherapies Focused on NK Cells Read more
Intensity Therapeutics Signs Clinical Collaboration Agreement with BMS for Advanced Solid Tumors Read more
Acceleron Receives FDA Breakthrough Therapy Designation for Sotatercept in Pulmonary Arterial Hypertension Read more
CSL Behring and SAB Biotherapeutics Join Forces to Deliver New Potential COVID-19 Therapeutic Read more